Compare BHVN & AAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHVN | AAMI |
|---|---|---|
| Founded | 2013 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2022 | N/A |
| Metric | BHVN | AAMI |
|---|---|---|
| Price | $14.38 | $80.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 3 |
| Target Price | $29.08 | ★ $58.00 |
| AVG Volume (30 Days) | ★ 2.9M | 433.1K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.61% |
| EPS Growth | ★ 26.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $32.73 |
| Revenue Next Year | N/A | $14.44 |
| P/E Ratio | ★ N/A | $23.86 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.48 | $39.20 |
| 52 Week High | $18.57 | $85.73 |
| Indicator | BHVN | AAMI |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 54.65 |
| Support Level | $14.17 | $69.97 |
| Resistance Level | $17.01 | $85.73 |
| Average True Range (ATR) | 0.99 | 2.42 |
| MACD | -0.29 | -0.06 |
| Stochastic Oscillator | 20.49 | 43.95 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.